Stem Cells and Autism
What is Autism?
Autism is a spectrum of disorders characterized by marked abnormalities in communication and social interactions.
Two common consistent findings are associated in children with this disorder:
1) diminished oxygenation in specific areas of the brain and
2) a chronic immunologically mediated inflammatory condition in the gut.
What is the rationale behind using stem cells to treat Autism?
Current investigative therapies for autism attempt to reverse these abnormalities through administration of antibiotics and anti‐inflammatory agents. Unfortunately, none of these approaches address the root causes of oxygen deprivation and intestinal inflammation. Mesenchymal stem cells can regulate the immune system. It is thought that they may help to reverse inflammatory conditions and is currently in the final stages of clinical trials in the US for Crohn’s disease, a condition resembling the gut inflammation in autistic children. The CD34 stem cells have been shown to induce generation of new blood vessels in tissue that lacks oxygen. It is thought that these stem cells may help increase the blood flow in the temporal region of the brain, an area that is believed to be inadequately oxygenated in autistic children.
We have observed improvement in patients treated at our facilities by using HBOT to mobilize “cascades” of the patient's own CD34+ stem cells.
Which types of stem cells are best to treat Autism and how are they obtained?
The CD 34+ stem cells are ideally suited for the treatment of Autism. HBOT exposure causes the bone marrow to mobilize cascades of CD 34+ stem cells from the patient's own body. Naturally, these cells are keyed with the patient's own DNA, therefore these stem cells pose no rejection risk because the body does not recognize them as foreign.
We offer two protocols to mobilize the CD 34+ stem cells:
- Two 60-minute hyperbaric exposures daily for 20 consecutive days (each exposure is for approximately 75-minutes in total duration)
- One 90-minute hyperbaric exposure daily for 10 consecutive days (each exposure is approximately 2- hours in total duration)
* It is suggested that the parent/caregiver read the University of Pennsylvania School of Medicine “Stem Cell Mobilization Study” Please click here for a copy of full study to understand how Hyperbaric Oxygen Therapy (HBOT) has been proven to mobilize CD 34+ stem cells after 40 cumulative hours of exposure..